T-box transcription factor TBX21 (TBX21)

T-box transcription factor TBX21, widely known as T-bet, is a master regulator of the type 1 immune response and a critical driver of Natural Killer (NK) cell maturation and effector function (Szabo et al., 2000). It operates by binding to specific DNA sequences, known as T-box elements, to promote the expression of key cytotoxic and pro-inflammatory genes, including IFNG, PRF1, and GZMB (Townsend et al., 2004). In the context of advanced cell therapies, T-bet is frequently overexpressed in iPSC-derived NK cells to overcome developmental immaturity and enhance their anti-tumor potency (Goldenson et al., 2022). This engineering strategy aims to produce highly functional, off-the-shelf NK cells capable of effectively targeting solid tumors and hematologic malignancies (Zhu et al., 2020). Beyond its role in NK cells, T-bet is essential for Th1 cell lineage commitment and is involved in the pathogenesis of various autoimmune and inflammatory diseases. While T-bet is not currently targeted by conventional small-molecule drugs, it is a central focus for genetic modification in adoptive immunotherapy and serves as a vital biomarker for assessing the functional state and potency of therapeutic immune cells.

Other names

T-betT-box protein 21T-petTBX21T-box transcription factor TBX21

T-bet functions as a transcription factor that binds to T-box elements in the promoter regions of target genes, facilitating the recruitment of histone-modifying complexes to promote the expression of type 1 cytokines and cytotoxic molecules (Szabo et al., 2000; Townsend et al., 2004).